Using a plant-based low protein diet to manage chronic kidney disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of a plant-dominant low protein diet, known as the PLADO diet, in reducing metabolic acidosis, a significant risk factor for the progression of chronic kidney disease (CKD). Participants will receive nutrition education on either the PLADO diet or the standard CKD diet through monthly sessions over six months, followed by checkups. The study aims to compare the two diets in terms of their impact on metabolic acidosis, as well as assess the safety, viability, and economic feasibility of the PLADO diet.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 18 years and above, having controlled glycemic and blood pressure parameters on treatment, with an established diagnosis of stages 3-5 CKD and an estimated GFR ≤59 ml/min/1.73 m2 stable for at least three months, and with a normal nutritional status as defined by the GLIM criteria, attending the CKD outpatient clinics at LAUMC-RH, willing to undergo the baseline screening and attend the monthly face-to-face visits at the outpatient department at LAUMC-RH.

Exclusion Criteria:

* Patients with overt infection, persistent anorexia, vomiting, or diarrhea within the last month, presence of wasting diseases such as cancer, tuberculosis, liver failure, heart failure, and those with serum potassium \>5.5 mEq/L during the past 6 months.

Where it's running

• Lebanese American University Medical Center- Rizk Hospital
  Beirut, Lebanon Recruiting

Study contacts

• Study coordinator: Rana Rizk, PhD, MS, MPH, LD
• Email: rana.rizk01@lau.edu.lb
• Phone: +9611786456

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Bicarbonate Levels in Hemodialysis Patients: A Look at Dialysis Details and Diet

  This observational study checks which factors influence bicarbonate in adults on maintenance dialysis to see how different dialysis practices and diet may affect metabolic balance.

  Recruiting East and North Hertfordshire NHS Trust · Stevenage, Hertfordshire · NCT07779200

• Sodium bicarbonate for critically ill patients with metabolic acidosis and AKI

  This trial tests whether giving sodium bicarbonate helps reduce major kidney problems 90 days later in adults with septic or critical illness and kidney injury.

  Recruiting Phase 4 Universität Münster · Münster · NCT07464431

• THAM vs. sodium bicarbonate for metabolic acidosis after cardiac surgery

  This trial tests whether THAM and sodium bicarbonate perform similarly to correct metabolic acidosis in patients having heart surgery with bypass.

  Recruiting Phase 4 Mayo Clinic · Rochester, Minnesota · NCT07424625

• Veverimer for metabolic acidosis in adults with chronic kidney disease.

  This 26-week trial will test whether veverimer can raise bicarbonate levels and improve outcomes in adults with moderate-to-severe CKD and metabolic acidosis.

  Recruiting at 27 sites Phase 3 Renibus Therapeutics, Inc. · Chula Vista, California and 27 other locations · NCT07355062

• Biomarker-guided treatment strategy for chronic kidney disease

  This trial will test whether using urine biomarkers to guide adding dapagliflozin, finerenone, and/or semaglutide can better reduce albuminuria and protect kidneys in adults with CKD.

  Recruiting Phase 4 Steno Diabetes Center Copenhagen · Herlev and 3 other locations · NCT07239570

• Algae supplements for heart risk markers and gut health

  This trial will test whether daily supplements of spirulina or Gelidium corneum change gut microbes and improve heart‑disease risk markers in adults over 50 with cardiovascular disease, diabetes, or related conditions.

  Recruiting Universidade do Porto · Porto · NCT07173062

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.